Medtronic Gains Offset by China VBP and Biologics
Despite share gains in its U.S. core spine products, Medtronic declined in the mid-single digits due to VBP in China and biologics declines. Aug 24, 2022
Orthopedic Companies Report Choppy Second Quarter of 2022
We estimate orthopedic sales were essentially flat against the prior year as the market faced difficult comparisons and macro headwinds. Aug 24, 2022
Medartis Revises 2022 Outlook Based on Headwinds
The company grew in the high teens for 1H22 but lowered its full-year guidance due to OR staffing headwinds and slower U.S. growth. Aug 18, 2022
Amplitude Surgical Growth Bolstered by Novastep Line
The company grew in the high single digits for its fiscal year 2022, driven in part by gains in its Novastep foot and ankle business. Aug 18, 2022
Medacta Continues Ascent in First Half of 2022
The company grew in the high teens for 1H22, driven by an expanded salesforce and further adoption of the NextAR surgical platform. Aug 17, 2022
Treace Medical Continues Gains Across Key Metrics
The company grew +45% in 2Q22 by driving increased market penetration and product utilization among its surgeon population. Aug 15, 2022
SI-BONE Sees Robust Demand and Increasing Utilization
The company grew in the mid-teens for the second quarter of 2022, attaining the most active surgeons in company history. Aug 15, 2022
ZimVie Makes Strides in Right-Sizing Business
The company declined in the high teens for 2Q22 as it works to establish new baselines for its sales geographies and portfolio. Aug 12, 2022
Orthofix Slides Due to Hospital Staffing Pressure
The company declined in the low-single digits in 2Q22 as hospital staffing pressures impacted case volumes for complex spine procedures. Aug 11, 2022
OrthoPediatrics Focused on Integrating Recent Acquisitions
The company grew over +20% in 2Q22, bolstered by revenue contributions from recently acquired Pega Medical and MD Orthopedics. Aug 11, 2022
